Ptc Therapeutics (PTCT) Debt to Equity (2012 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Debt to Equity of -$1.69 in Q1 2026, down 21.08% quarter-over-quarter from -$1.4 in Q4 2025, and up 41.19% on a YoY basis from -$1.2 in Q1 2025.
Ptc Therapeutics (PTCT) Debt to Equity (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Debt to Equity history runs 15 years deep, the most recent figure standing at -$1.69 for Q1 2026.
- In Q1 2026, Debt to Equity rose 41.19% year-over-year to -$1.69; the TTM figure through Mar 2026 stood at -$1.69 (up 41.19% YoY), while the FY2025 annual figure was -$1.4, down 182.2% from the prior year.
- Debt to Equity was -$1.69 for Q1 2026 at Ptc Therapeutics, down from -$1.4 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.49 in Q4 2024 to a low of -$3.89 in Q1 2022.
- Historically, Debt to Equity has averaged -$1.55 across 5 years, with a median of -$1.46 in 2023.
- The sharpest annual moves came in 2023 and 2025: Debt to Equity soared 68.49% in 2023, then plunged 402.23% in 2025.
- A 5-year view of Debt to Equity shows it stood at -$1.86 in 2022, then jumped by 68.49% to -$0.58 in 2023, then advanced by 15.38% to -$0.49 in 2024, then plunged by 182.2% to -$1.4 in 2025, then slipped by 21.08% to -$1.69 in 2026.
- The last three Debt to Equity figures came in at -$1.69 (Q1 2026), -$1.4 (Q4 2025), and -$1.67 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | -1.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.69 |
| Dec 31, 2025 | -1.40 |
| Sep 30, 2025 | -1.67 |
| Jun 30, 2025 | -2.65 |
| Mar 31, 2025 | -2.87 |
| Dec 31, 2024 | -0.49 |
| Sep 30, 2024 | -0.51 |
| Jun 30, 2024 | -0.55 |
| Mar 31, 2024 | -0.57 |
| Dec 31, 2023 | -0.58 |
| Sep 30, 2023 | -1.01 |
| Jun 30, 2023 | -1.17 |
| Mar 31, 2023 | -1.46 |
| Dec 31, 2022 | -1.86 |
| Sep 30, 2022 | -1.59 |
| Jun 30, 2022 | -2.37 |
| Mar 31, 2022 | -3.89 |
| Dec 31, 2021 | 237.26 |
| Sep 30, 2021 | 3.19 |
| Jun 30, 2021 | 2.42 |